[lou_lou]

MICHEL F. LEVESQUE, MD, FRCS (C), FACS, DIRECTOR

http://www.lansi.org/index.html - homepage

http://www.lansi.org/team.html

Michel Lévesque, MD, FRCS, FACS is a world-renowned neuroscientist and neurosurgeon based at Cedars-Sinai Medical Center in Los Angeles. He is an Associate Clinical Professor of Neurosurgery at the UCLA School of Medicine and member of the UCLA Brain Research Institute.
He is the Chairman of the Foundation for Neural Repair, a not-for-profit foundation, sponsoring translational research to accelerate human trials using neural stem cells. He has authored over 100 articles in professional journals, contributed chapters to many leading neurosurgery treatises, and has published over 200 scientific abstracts.

Lévesque received his medical degree at University of Montreal in 1979 and underwent post-graduate studies in Neurosciences on central nervous system regeneration and transplantation at the Montreal General Hospital and McGill University. He completed his neurosurgical training at the Montreal Neurological Institute and a fellowship in functional and spinal neurosurgery in 1986. Board-Certified by the American Board of Neurological Surgery and the Royal College of Physicians and Surgeons of Canada, Dr. Levesque has been in practice for over 20 years in Los Angeles. He is the recipient of the
prestigious "America's Top Surgeon" award and other numerous awards related to his groundbreaking work in neuroregeneration. Dr. Levesque is the Director of the Los Angeles Neurosurgical Institute. He is a member of several professional organizations, including the American Association of Neurological Surgeons, American College of Surgeons and the American Association for the Advancement of Science and serves on the board of
The Foundation for Neural Repair.

~~~~~~~~~~~~


MOVEMENT DISORDERS

& PARKINSON'S DISEASE

http://www.lansi.org/movement_disorders_new.html

The Movement Disorders Surgery Program at the LANSI is a vital resource for individuals suffering from Parkinson's disease or other movement disorders, including drug-induced dyskinesias, dystonias and atypical tremors that have been unresponsive to traditional treatment.

Because the nature of movement disorders is so unique, each patient receives an individually tailored treatment plan. In addition, the Movement Disorders Surgery Program provides a holistic approach to patient care, addressing the social and emotional problems that can accompany a chronic illness.

[aftermathman]

have you any idea of the timeframe for Neurogeneration's PII PD clinical trial which Michel Lévesque claims is FDA approved but on hold ?

http://www.neurogeneration.com/clinical/ourp.html

"This FDA-approved study has been placed on hold pending completion of a cell processing facility meeting strict cGMP standards, including monitoring of processes, optimization of the isolation and expansion techniques and animal studies of cell migration and phenotypes after long term transplantation".

Neil.

[lou_lou]

Originally Posted by aftermathman

have you any idea of the timeframe for Neurogeneration's PII PD clinical trial which Michel Lévesque claims is FDA approved but on hold ?

http://www.neurogeneration.com/clinical/ourp.html

"This FDA-approved study has been placed on hold pending completion of a cell processing facility meeting strict cGMP standards, including monitoring of processes, optimization of the isolation and expansion techniques and animal studies of cell migration and phenotypes after long term transplantation".

Neil.

I will call and find out,
get back to you when I get an answer from Dr. Levesque...
peace,
tena